Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimating the burden of vitiligo: a systematic review and modelling study.
Akl J, Lee S, Ju HJ, Parisi R, Kim JY, Jeon JJ, Heo YW, Eleftheriadou V, Hamzavi I, Griffiths CEM, Ashcroft DM, Mysore V, Gupta S, Parsad D, Lim H, Bae JM, Ezzedine K; Global Vitiligo Atlas. Akl J, et al. Among authors: hamzavi i. Lancet Public Health. 2024 Mar 26:S2468-2667(24)00026-4. doi: 10.1016/S2468-2667(24)00026-4. Online ahead of print. Lancet Public Health. 2024. PMID: 38552651 Free article.
Vitiligo is not a cosmetic disease.
Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, Pandya AG; Vitiligo Working Group. Ezzedine K, et al. J Am Acad Dermatol. 2015 Nov;73(5):883-5. doi: 10.1016/j.jaad.2015.07.039. J Am Acad Dermatol. 2015. PMID: 26475548 No abstract available.
Vitiligo.
Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Picardo M, et al. Among authors: hamzavi i. Nat Rev Dis Primers. 2015 Jun 4;1:15011. doi: 10.1038/nrdp.2015.11. Nat Rev Dis Primers. 2015. PMID: 27189851 Review.
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
van Geel N, Duponselle J, Delbaere L, Herbelet S, Eleftheriadou V, Ezzedine K, Forman M, Garg A, Hamzavi IH, Seneschal J, Spuls P, Terwee CB, Wolkerstorfer A, Speeckaert R, Pandya AG. van Geel N, et al. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2231-2242. doi: 10.1111/jdv.19448. Epub 2023 Sep 11. J Eur Acad Dermatol Venereol. 2023. PMID: 37602494 Review.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
van Geel N, Speeckaert R, Taïeb A, Ezzedine K, Lim HW, Pandya AG, Passeron T, Wolkerstorfer A, Abdallah M, Alomar A, Bae JM, Bekkenk M, Benzekri L, Böhm M, Eleftheriadou V, Esmat S, Ghia D, Goh BK, Grimes P, Gupta S, Hamzavi IH, Harris JE, Oh SH, Huggins R, Katayama I, Lan E, Lee AY, Leone G, Le Poole C, Lui H, Maquignon N, Meurant JM, Monteiro P, Oiso N, Parsad D, Pliszewski G, Raboobee N, Rodrigues M, Rosmarin D, Suzuki T, Tanemura A, Thng S, Xiang F, Zhou Y, Picardo M, Seneschal J. van Geel N, et al. Among authors: hamzavi ih. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2173-2184. doi: 10.1111/jdv.19451. Epub 2023 Sep 25. J Eur Acad Dermatol Venereol. 2023. PMID: 37746876
Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N, Hamzavi IH, Pandya AG, Wolkerstorfer A, Seneschal J, Garg A, Spuls P, Terwee CB, Mallett S, Speeckaert R, Meurant JM, Eleftheriadou V, Ezzedine K. van Geel N, et al. Trials. 2022 Jul 23;23(1):591. doi: 10.1186/s13063-022-06497-1. Trials. 2022. PMID: 35871019 Free PMC article.
269 results